ArticleBiotech (Basel (Switzerland))2025

Strategy for the Construction of SARS-CoV-2 S and N Recombinant Proteins and Their Immunogenicity Evaluation.

Paulo Henrique Guilherme Borges et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.